GlassScriptPhysician profile
Daniel Mark Seeser
NPI 1376162990
$3,061.85
in general payments reported to CMS, 2019-2025
33 companies · $1,261 in 2025
The $1,261 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $118 · 2022: $60.65 · 2023: $459 · 2024: $1,164 · 2025: $1,261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,868 · Education: $15.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,867.61 |
| Education | $15.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $626.81 | 2023-2025 | Linzess, Vraylar, Viberzi |
| Astrazeneca Pharmaceuticals LP | $459.75 | 2023-2025 | Farxiga, Breztri, Airsupra |
| Novo Nordisk INC | $279.11 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbott Laboratories | $184.84 | 2023-2025 | Freestyle Libre 3 |
| Astellas Pharma US INC | $175.92 | 2023-2025 | Veozah |
| Lilly USA, LLC | $170.01 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Dexcom, INC. | $146.23 | 2024-2025 | Dexcom G6 Transmitter |
| Axsome Therapeutics, INC. | $111.39 | 2024-2025 | Auvelity |
| Esperion Therapeutics, INC. | $104.81 | 2021 | |
| Pfizer INC. | $91.89 | 2024-2025 | |
| Exact Sciences Corporation | $80.88 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $51.31 | 2025 | |
| Merck Sharp & Dohme LLC | $48.23 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Kestra Medical Technology Services, INC. | $46.74 | 2025 | Assure Wcd |
| Gilead Sciences, INC. | $45.28 | 2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $43.65 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $43.08 | 2022 | |
| Intuitive Surgical, INC. | $38.89 | 2023 | Da Vinci Surgical System |
| Amgen INC. | $36.55 | 2023-2024 | Evenity, Prolia |
| Glaxosmithkline, LLC. | $30.70 | 2024 | Trelegy Ellipta, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $28.65 | 2023-2025 | Xifaxan, Trulance |
| Sumitomo Pharma America, INC. | $28.41 | 2024 | Gemtesa |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $25.16 | 2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.43 | 2024 | Ofev |
| Tactile Systems Technology INC | $23.11 | 2023 | Entre Plus, Flexitouch Plus |
| Otsuka America Pharmaceutical, INC. | $19.92 | 2024 | Rexulti |
| Lundbeck LLC | $18.47 | 2025 | Rexulti |
| Supernus Pharmaceuticals, INC. | $16.31 | 2024 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $15.39 | 2024 | Trintellix |
| Currax Pharmaceuticals LLC | $14.36 | 2023 | Contrave, Nexlizet, Nexletol |
| Edwards Lifesciences Corporation | $13.39 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.93 | 2023 | Livalo, Seglentis |
| Kerecis Limited | $6.25 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Seeser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.